The effects of methylphenidate on weight, height, and body mass index in Turkish children and adolescents with ADHD

被引:3
|
作者
Turan, Serkan [1 ]
PEKCANLAR Akay, Aynur [2 ]
机构
[1] Odemis State Hosp, Dept Child & Adolescent Psychiat, TR-35750 Izmir, Turkey
[2] Dokuz Eylul Univ, Dept Child & Adolescent Psychiat, Med Fac, Izmir, Turkey
来源
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY | 2020年 / 21卷 / 02期
关键词
methylphenidate; attention-deficit hyperactivity disorder; height; weight; BMI; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GROWTH; ASSOCIATION;
D O I
10.5455/apd.51135
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The pathophysiological mechanisms underlying the effects of psychostimulants (methylphenidate) treatment on growth still remain controversial. We examined the long term effects of methylphenidate on height, weight and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder (ADHD). Methods: Participants (6-18 years, 330 boys, 103 girls) diagnosed with ADHD who received treatment with methylphenidate for at least 1 year at the Department of Child and Adolescent Psychiatry at Dokuz Eylul University Medical School were included in a retrospective study. Weight, height, and BMI z scores were converted to age- and gender-corrected z scores using norms from the Turkish population at baseline and last follow-up. Results: Height and weight standard deviation score (SDS) were reduced by treatment (baseline height-SDS (SDS]: 0.74 +/- 1.43, followup height-SDS [SDS]: -0.67 +/- 4.35, t-test p<0.001; baseline weight SDS [SDS]: 0.61 +/- 1.28, and follow-up weight-SDS [SDS]: -0.41 +/- 0.76, t-test p<0.001). There were no differences in BMI-SDS before and after stimulant treatment (baseline BMI-SDS [SDS]: 0.27 +/- 1.21, follow-up BMI-SDS [SDS]: -0.20 +/- 4.54, t-test p=0.353). However, considering whether patients were children (6-12 years) or adolescents (13-18 years) when they started medication, in the group of children, height and BMI was affected by treatment (baseline height-SDS [SDS]: 0.87 +/- 1.42; follow-up height-SDS [SDS]: -0.78 +/- 4.81]; p=0.002; baseline BMI-SDS [SDS]: 0.29 +/- 1.19; follow-up BMI-SDS [SDS]: -0.21 +/- 0.69; p<0.001). Results of multiple linear regression analysis which assess the possible contribution of the different treatment-related factors, only age starting treatment (B=-0.039, p=0.011) predicted final weight. Conclusions: We conclude that methylphenidate shows a negative effect on height and BMI in children. It was thought that the findings obtained at the end of the study might be helpful in assessing the growth parameters that may facilitate the course of the ADHD, and in the improvement of more efficient and permanent treatment approaches, and the adherence of patients to the treatment.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 50 条
  • [1] The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder
    Turan, Serkan
    Akay, Aynur Pekcanlar
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 29 (04) : 781 - 786
  • [2] Reference values for height, weight and body mass index of German born Turkish children
    Redlefsen, Tine
    Commentz, Jens
    Meigen, Christof
    Hermanussen, Michael
    ANTHROPOLOGISCHER ANZEIGER, 2007, 65 (03) : 263 - 274
  • [3] Impact of Long-Term Treatment of Methylphenidate on Height and Weight of School Age Children with ADHD
    Zhang, H.
    Du, M.
    Zhuang, S.
    NEUROPEDIATRICS, 2010, 41 (02) : 55 - 59
  • [4] Reference Values for Weight, Height, Head Circumference, and Body Mass Index in Turkish Children
    Neyzi, Olcay
    Bundak, Ruveyde
    Gokcay, Gulbin
    Gunoz, Hulya
    Furman, Andrzej
    Darendeliler, Feyza
    Bas, Firdevs
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2015, 7 (04) : 280 - 293
  • [5] Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate
    Diez-Suarez, Azucena
    Vallejo-Valdivielso, Maria
    Marin-Mendez, Juan J.
    de Castro-Manglano, Pilar
    Soutullo, Cesar A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (08) : 723 - 730
  • [6] Effects of Osmotic-Release Methylphenidate on Height and Weight in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Following up to Four Years of Treatment
    Dura-Trave, Teodoro
    Eugenia Yoldi-Petri, Maria
    Gallinas-Victoriano, Fidel
    Zardoya-Santos, Patricia
    JOURNAL OF CHILD NEUROLOGY, 2012, 27 (05) : 604 - 609
  • [7] Body Mass Index Changes in Children and Adolescents Treated with Methylphenidate forAttention Deficit Hyperactivity Disorder
    Kousha, Maryam
    Asli, Samaneh Hasanpour
    Eslamdoust-Siahestalkhi, Fatemeh
    Shoar, Yasmin
    Shoar, Zohreh
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2024, 18 (02) : 73 - 82
  • [8] Height, weight, and body mass index associations with gastric cancer subsites
    Camargo, M. Constanza
    Freedman, Neal D.
    Hollenbeck, Albert R.
    Abnet, Christian C.
    Rabkin, Charles S.
    GASTRIC CANCER, 2014, 17 (03) : 463 - 468
  • [9] Evaluation of Weight, Height, Body Mass Index, and Nutritional Status of Children With and Without Orofacial Cleft in Nigeria
    Egbunah, Uchenna P.
    Zhu, Yaner T.
    Ratz, Tiara
    Hauri, Dimitri D.
    Thor, Andreas L. I.
    Adeyemo, Wasiu L.
    CLEFT PALATE CRANIOFACIAL JOURNAL, 2024,
  • [10] Methylphenidate HCL for the treatment of ADHD in children and adolescents
    Childress, Ann C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (08) : 1171 - 1178